Helicobacter pylori multiplex serology

Helicobacter

Volumn 14, Issue 6, 2009, Pages 525-535

  Michel, Angelika ^a   Waterboer, Tim ^a   Kist, Manfred ^b   Pawlita, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibody profiling; Gastric cancer; Helicobacter; High throughput; Luminex; Seroepidemiology

Indexed keywords

ANTIBODY; ANTIGEN; BACTERIAL PROTEIN; CAD PROTEIN; CAGA PROTEIN; CAGM PROTEIN; CATALASE; CHAPERONIN; GLUTATHIONE TRANSFERASE; HCPC PROTEIN; HYBRID PROTEIN; NAPA PROTEIN; OMP PROTEIN; PROTEIN; UNCLASSIFIED DRUG; UREA PROTEIN; VACUOLATING TOXIN;

ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SEROLOGY; SERUM; VALIDATION STUDY; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; SEROLOGIC TESTS;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 70449442527     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00723.x     Document Type: Article

References (39)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994 61 : 1 241.
2. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997 10 : 720 741.
3. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007 117 : 60 9.
4. van Amsterdam K, van Vliet AH, Kusters JG, van der Ende A. Of microbe and man: determinants of Helicobacter pylori-related diseases. FEMS Microbiol Rev 2006 30 : 131 156.
5. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995 63 : 94 8.
6. Salama SM, Wefuan JN, Shiro-Koulla S, Mbakop A, Tagni-Sartre M, Ndam EC, Ngu JL, Taylor DE. Value of whole-cell antigen extracts for serologic detection of Helicobacter pylori. J Clin Microbiol 1993 31 : 3331 3332.
7. Lepper PM, Moricke A, Vogt K, Bode G, Trautmann M. Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection. Clin Diagn Lab Immunol 2004 11 : 569 576.
8. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001 121 : 784 791.
9. Krah A, Miehlke S, Pleissner KP, Zimny-Arndt U, Kirsch C, Lehn N, et al. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer 2004 108 : 456 463.
10. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2002 2 : 313 324.
11. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem 2005 51 : 1845 1853.
12. Rizk RZ, Christensen ND, Michael KM, Muller M, Sehr P, Waterboer T, et al. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol. 2008 89 (Pt 1 117 129.
13. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997 388 (6642 539 547.
14. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993 90 : 5791 5795.
15. Apel I, Jacobs E, Kist M, Bredt W. Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg [A] 1988 268 : 271 276.
16. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001 253 : 153 162.
17. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006 309 : 200 204.
18. Muller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, et al. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 1992 187 : 508 514.
19. Bumann D, Jungblut PR, Meyer TF. Helicobacter pylori vaccine development based on combined subproteome analysis. Proteomics 2004 4 : 2843 2848.
20. Sabarth N, Lamer S, Zimny-Arndt U, Jungblut PR, Meyer TF, Bumann D. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J Biol Chem 2002 277 : 27896 27902.
21. Buhling F, Koch G, Wex T, Heimburg A, Vieth M, Leodolter A, et al. Simultaneous detection and differentiation of anti-Helicobacter pylori antibodies by flow microparticle immunofluorescence assay. Clin Diagn Lab Immunol 2004 11 : 131 136.
22. Manetti R, Massari P, Burroni D, de Bernard M, Marchini A, Olivieri R, et al. Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun 1995 63 : 4476 4480.
23. Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997 29 : 147 151.
24. Kist M, Strobel S, Kirchner T, Dammann HG. Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study. FEMS Immunol Med Microbiol 1999 24 : 239 242.
25. Siman JH, Engstrand L, Berglund G, Floren CH, Forsgren A. Evaluation of Western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects. Clin Diagn Lab Immunol 2005 12 : 304 309.
26. Yamaguchi H, Osaki T, Kurihara N, Taguchi H, Hanawa T, Yamamoto T, et al. Heat-shock protein 60 homologue of Helicobacter pylori is associated with adhesion of H. pylori to human gastric epithelial cells. J Med Microbiol 1997 46 : 825 831.
27. Takenaka R, Yokota K, Ayada K, Mizuno M, Zhao Y, Fujinami Y, et al. Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 2004 150 (Pt 12 3913 3922.
28. Harris AG, Wilson JE, Danon SJ, Dixon MF, Donegan K, Hazell SL. Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology 2003 149 (Pt 3 665 672.
29. Wang G, Hong Y, Olczak A, Maier SE, Maier RJ. Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun 2006 74 : 6839 6846.
30. Namavar F, Sparrius M, Veerman EC, Appelmelk BJ, Vandenbroucke-Grauls CM. Neutrophil-activating protein mediates adhesion of Helicobacter pylori to sulfated carbohydrates on high-molecular-weight salivary mucin. Infect Immun 1998 66 : 444 447.
31. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W, Melchers K, et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003 197 : 813 822.
32. Deml L, Aigner M, Decker J, Eckhardt A, Schutz C, Mittl PR, et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect Immun 2005 73 : 4732 4742.
33. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori Cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001 42 : 1337 1348.
34. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994 269 : 10566 10573.
35. Atherton JC, Cao P, Peek RM Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific VacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995 270 : 17771 17777.
36. Monstein HJ, Ellnebo-Svedlund K. Molecular typing of Helicobacter pylori by virulence-gene based multiplex PCR and RT-PCR analysis. Helicobacter 2002 7 : 287 296.
37. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007 133 : 926 936.
38. Gao L, Weck MN, Michel A, Pawlita M, Brenner H. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res 2009 69 : 2973 2980.
39. Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 Helicobacter pylori proteins determined by novel multiplex serology. Cancer Res 2009 65 : 6164 6170.